{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:15:34Z","timestamp":1786976134085,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd010750","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,3,13]],"date-time":"2015-03-13T00:00:00Z","timestamp":1426204800000}}],"reference-count":90,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010750.pub2","type":"journal-article","created":{"date-parts":[[2015,3,13]],"date-time":"2015-03-13T13:09:53Z","timestamp":1426252193000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pharmacological interventions for pain in children and adolescents with life-limiting conditions"],"prefix":"10.1002","volume":"2017","author":[{"given":"Emma","family":"Beecham","sequence":"first","affiliation":[{"name":"Marie Curie Palliative Care Research Department, UCL Division of Psychiatry; Charles Bell House 67-73 Riding House Street London UK W1W 7EJ"},{"name":"UCL Institute of Child Health; Louis Dundas Centre for Children's Palliative Care; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Candy","sequence":"additional","affiliation":[{"name":"Marie Curie Palliative Care Research Department, UCL Division of Psychiatry; Charles Bell House 67-73 Riding House Street London UK W1W 7EJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Howard","sequence":"additional","affiliation":[{"name":"Great Ormond Street Hospital; Anaesthesia and Pain Management; Great Ormond Street London UK WC1N 3JH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9e","family":"McCulloch","sequence":"additional","affiliation":[{"name":"Great Ormond Street Hospital; Louis Dundas Centre for Children's Palliative Care, Palliative Care Team; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Laddie","sequence":"additional","affiliation":[{"name":"Evelina London Children's Hospital; Department of Paediatric Palliative Medicine; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrietta","family":"Rees","sequence":"additional","affiliation":[{"name":"UCL Institute of Child Health; Louis Dundas Centre for Children's Palliative Care; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Vickerstaff","sequence":"additional","affiliation":[{"name":"Marie Curie Palliative Care Research Department, UCL Division of Psychiatry; Charles Bell House 67-73 Riding House Street London UK W1W 7EJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myra","family":"Bluebond-Langner","sequence":"additional","affiliation":[{"name":"UCL Institute of Child Health; Louis Dundas Centre for Children's Palliative Care; London UK"},{"name":"Rutgers University; Department of Sociology, Anthropology and Criminal Justice; Camden New Jersey USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Jones","sequence":"additional","affiliation":[{"name":"Marie Curie Palliative Care Research Department, UCL Division of Psychiatry; Charles Bell House 67-73 Riding House Street London UK W1W 7EJ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,3,13]]},"reference":[{"key":"10.1002\/14651858.CD010750.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/S0140-6736(13)61091-0","article-title":"Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial","volume":"382","author":"Bishop","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD010750.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ejpn.2011.05.003","article-title":"Effects of intrathecal baclofen on daily care in children with secondary generalized dystonia: a pilot study","volume":"15","author":"Bonouvrie","year":"2011","journal-title":"European Journal of Paediatric Neurology"},{"issue":"1","key":"10.1002\/14651858.CD010750.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jpeds.2014.01.050","article-title":"Botulinum toxin A for nonambulatory children with cerebral palsy: a double blind randomized controlled trial","volume":"165","author":"Copeland","year":"2014","journal-title":"The Journal of Pediatrics"},{"issue":"9","key":"10.1002\/14651858.CD010750.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1469-8749.2007.00654.x","article-title":"Intrathecal baclofen in children with spastic cerebral palsy: a double-blind, randomized, placebo-controlled, dose-finding study","volume":"49","author":"Hoving","year":"2007","journal-title":"Developmental Medicine & Child Neurology"},{"issue":"3","key":"10.1002\/14651858.CD010750.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejpn.2008.04.013","article-title":"Efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy: A randomised controlled trial","volume":"13","author":"Hoving","year":"2009","journal-title":"European Journal of Paediatric Neurology"},{"issue":"3","key":"10.1002\/14651858.CD010750.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ejpn.2008.05.002","article-title":"Safety and one-year efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy","volume":"13","author":"Hoving","year":"2009","journal-title":"European Journal of Paediatric Neurology"},{"key":"10.1002\/14651858.CD010750.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"977-86","DOI":"10.1359\/JBMR.050109","article-title":"Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement","volume":"20","author":"Letocha","year":"2005","journal-title":"Journal of Bone and Mineral Research"},{"issue":"5","key":"10.1002\/14651858.CD010750.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"e1149","DOI":"10.1542\/peds.2006-2425","article-title":"Upper-limb botulinum toxin A injection and occupational therapy in children with hemiplegic cerebral palsy identified from a population register: A single-blind, randomized, controlled trial","volume":"119","author":"Russo","year":"2007","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD010750.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/01.bpo.0000176162.78980.ed","article-title":"Impact of alendronate on quality of life in children with osteogenesis imperfecta","volume":"25","author":"Seikaly","year":"2005","journal-title":"Journal of Pediatric Orthopedics"},{"issue":"2","key":"10.1002\/14651858.CD010750.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1210\/jc.2010-0636","article-title":"Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study","volume":"96","author":"Ward","year":"2011","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"4","key":"10.1002\/14651858.CD010750.pub2-BIB0011|cit11","first-page":"322","article-title":"The clinical and radiological assessment of cyclic intravenous pamidronate administration in children with osteogenesis imperfecta","volume":"46","author":"Adiyaman","year":"2004","journal-title":"Turkish Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD010750.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1695-4033(02)77923-X","article-title":"Treatment of pain in a case of osteogenesis imperfecta type III","volume":"57","author":"Alvarez Lopez","year":"2002","journal-title":"Anales Espa\u00f1oles de Pediatr\u00eda"},{"issue":"1","key":"10.1002\/14651858.CD010750.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1515\/JPEM.2008.21.1.63","article-title":"Cyclic pamidronate therapy in children with osteogenesis imperfecta: results of treatment and follow-up after discontinuation","volume":"21","author":"Andiran","year":"2008","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD010750.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1651-2227.1998.tb01388.x","article-title":"Beneficial effect of bisphosphonate during five years of treatment of severe osteogenesis imperfecta","volume":"87","author":"Astrom","year":"1998","journal-title":"Acta Paediatrica"},{"issue":"5","key":"10.1002\/14651858.CD010750.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/adc.86.5.356","article-title":"Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta","volume":"86","author":"Astrom","year":"2002","journal-title":"Archives of Disease in Childhood"},{"issue":"12","key":"10.1002\/14651858.CD010750.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1651-2227.2010.01968.x","article-title":"Biochemical bone markers in the assessment and pamidronate treatment of children and adolescents with osteogenesis imperfecta","volume":"99","author":"Astrom","year":"2010","journal-title":"Acta Paediatrica"},{"issue":"6","key":"10.1002\/14651858.CD010750.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"562-3","DOI":"10.1136\/adc.87.6.562-a","article-title":"Osteogenesis imperfecta and intravenous pamidronate","volume":"87","author":"Banerjee","year":"2002","journal-title":"Archives of Disease in Childhood"},{"issue":"5-6","key":"10.1002\/14651858.CD010750.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1515\/jpem-2012-0016","article-title":"Safety and efficacy of a 1-year treatment with zoledronic acid compared with pamidronate in children with osteogenesis imperfecta","volume":"25","author":"Barros","year":"2012","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD010750.pub2-BIB0019|cit19","first-page":"33","article-title":"Osteogenesis imperfecta","volume":"57","author":"Bhadada","year":"2009","journal-title":"Journal of the Association of Physicians of India"},{"issue":"5","key":"10.1002\/14651858.CD010750.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"e1363","DOI":"10.1542\/peds.2007-1468","article-title":"Effect of low-dose naloxone infusion on fentanyl requirements in critically ill children","volume":"121","author":"Darnell","year":"2008","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD010750.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1515\/JPEM.2005.18.1.43","article-title":"A comparison of oral and intravenous bisphosphonate therapy for children with osteogenesis imperfecta","volume":"18","author":"Dimeglio","year":"2005","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD010750.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1359\/JBMR.051006","article-title":"Two-year clinical trial of oral alendronate versus intravenous pamidronate in children with osteogenesis imperfecta","volume":"21","author":"DiMeglio","year":"2006","journal-title":"Journal of Bone and Mineral Research"},{"issue":"10","key":"10.1002\/14651858.CD010750.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.2106\/JBJS.K.00751","article-title":"Efficacy of alendronate in the treatment of low bone density in the pediatric and young adult population","volume":"94","author":"Dominguez-Bartmess","year":"2012","journal-title":"The Journal of Bone and Joint Surgery. American volume"},{"issue":"3","key":"10.1002\/14651858.CD010750.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1542\/peds.111.3.573","article-title":"Intravenous bisphosphonate therapy in children with osteogenesis imperfecta","volume":"111","author":"Falk","year":"2003","journal-title":"Pediatrics"},{"issue":"12","key":"10.1002\/14651858.CD010750.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1002\/cncr.21497","article-title":"Transdermal fentanyl in the management of children with chronic severe pain","volume":"104","author":"Finkel","year":"2005","journal-title":"Cancer"},{"issue":"4","key":"10.1002\/14651858.CD010750.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jbspin.2004.08.011","article-title":"Benefits of pamidronate in children with osteogenesis imperfecta: an open prospective study","volume":"72","author":"Forin","year":"2005","journal-title":"Joint, Bone, Spine: Revue du Rhumatisme"},{"issue":"10","key":"10.1002\/14651858.CD010750.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1517\/17425250903029190","article-title":"Neridronic acid for the treatment of bone metabolic diseases","volume":"5","author":"Gatti","year":"2009","journal-title":"Expert Opinion on Drug Metabolism and Toxicology"},{"issue":"14","key":"10.1002\/14651858.CD010750.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","article-title":"Cyclic administration of pamidronate in children with severe osteogenesis imperfecta","volume":"339","author":"Glorieux","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD010750.pub2-BIB0029|cit29","first-page":"529","article-title":"Efficacy of low dose schedule pamidronate infusion in children with osteogenesis imperfecta","volume":"14","author":"Gonzalez","year":"2001","journal-title":"Journal of Pediatric Endocrinology"},{"issue":"7","key":"10.1002\/14651858.CD010750.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.clinph.2006.04.014","article-title":"Placebo controlled utility and feasibility study of the H-reflex and flexor reflex in spastic children treated with intrathecal baclofen","volume":"117","author":"Hoving","year":"2006","journal-title":"Clinical Neurophysiology"},{"issue":"3","key":"10.1002\/14651858.CD010750.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ejpn.2008.05.002","article-title":"Safety and one-year efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy","volume":"13","author":"Hoving","year":"2009","journal-title":"European Journal of Paediatric Neurology"},{"issue":"6","key":"10.1002\/14651858.CD010750.pub2-BIB0032|cit32","first-page":"593","article-title":"New trends in the treatment of osteogenesis imperfecta type III - own experience","volume":"10","author":"Jakubowska-Pietkiewicz","year":"2008","journal-title":"Ortopedia Traumatologia Rehabilitacja"},{"issue":"3","key":"10.1002\/14651858.CD010750.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"185","DOI":"10.55095\/achot2008\/036","article-title":"Role of an interdisciplinary approach in the healing of long bone fractures in patients with osteogenesis imperfecta","volume":"75","author":"Kokavec","year":"2008","journal-title":"Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca"},{"issue":"3","key":"10.1002\/14651858.CD010750.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.bone.2006.10.010","article-title":"Osteogenesis imperfecta type VI in childhood and adolescence: Effects of cyclical intravenous pamidronate treatment","volume":"40","author":"Land","year":"2007","journal-title":"Bone"},{"key":"10.1002\/14651858.CD010750.pub2-BIB0035|cit35","first-page":"1375","article-title":"A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes","volume":"98","author":"Morris","year":"2013","journal-title":"Red Cell Disorders"},{"issue":"5","key":"10.1002\/14651858.CD010750.pub2-BIB0036|cit36","first-page":"1846-50","article-title":"Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age","volume":"85","author":"Plotkin","year":"2000","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"3","key":"10.1002\/14651858.CD010750.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0923-2532(02)01186-9","article-title":"Biological monitoring of osteogenesis imperfecta. [French] Suivi de l'osteogenese imparfaite traitee","volume":"17","author":"Pressac","year":"2002","journal-title":"Immuno-Analyse et Biologie Specialisee"},{"issue":"7","key":"10.1002\/14651858.CD010750.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1359\/jbmr.090213","article-title":"Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study","volume":"24","author":"Rauch","year":"2009","journal-title":"Journal of Bone and Mineral Research"},{"issue":"5","key":"10.1002\/14651858.CD010750.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00520-006-0193-8","article-title":"Safety and efficacy of fentanyl administered by patient controlled analgesia in children with cancer pain","volume":"15","author":"Ruggiero","year":"2007","journal-title":"Supportive Care in Cancer"},{"issue":"3","key":"10.1002\/14651858.CD010750.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/pbc.24332","article-title":"Efficacy and safety of transdermal buprenorphine in the management of children with cancer-related pain","volume":"60","author":"Ruggiero","year":"2013","journal-title":"Pediatric Blood & Cancer"},{"issue":"2","key":"10.1002\/14651858.CD010750.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"144-50","DOI":"10.1016\/S0022-3476(99)70407-5","article-title":"Advantages of fentanyl over morphine in analgesia for ventilated newborn infants after birth: A randomized trial","volume":"134","author":"Saarenmaa","year":"1999","journal-title":"The Journal of Pediatrics"},{"issue":"9419","key":"10.1002\/14651858.CD010750.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(04)16101-1","article-title":"Skeletal effects and functiona outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study","volume":"363","author":"Sakkers","year":"2004","journal-title":"Lancet"},{"issue":"1-2","key":"10.1002\/14651858.CD010750.pub2-BIB0043|cit43","first-page":"73","article-title":"Cyclic pamidronate therapy in children with osteogenesis imperfecta","volume":"23","author":"Salehpour","year":"2010","journal-title":"Journal of Pediatric Endocrinology"},{"issue":"5","key":"10.1002\/14651858.CD010750.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/0883073807302601","article-title":"Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy","volume":"22","author":"Sanger","year":"2007","journal-title":"Journal of Child Neurology"},{"issue":"3","key":"10.1002\/14651858.CD010750.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00006123-200003000-00017","article-title":"Intrathecal baclofen for intractable cerebral spasticity: a prospective placebo-controlled, double-blind study","volume":"46","author":"Schaeybroeck","year":"2000","journal-title":"Neurosurgery"},{"issue":"7","key":"10.1002\/14651858.CD010750.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1210\/jc.2004-2054","article-title":"Single-dose pharmacokinetics and tolerability of alendronate 35- and 70-milligram tablets in children and adolescents with osteogenesis imperfecta type I","volume":"90","author":"Ward","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"51","key":"10.1002\/14651858.CD010750.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1542\/peds.111.5.1030","article-title":"Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV","volume":"111","author":"Zeitlin","year":"2003","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD010750.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/1471-2431-13-175","article-title":"Intrathecal baclofen treatment in dystonic cerebral palsy: a randomized clinical trial: the IDYS trial","volume":"13","author":"Bonouvri\u00e9","year":"2013","journal-title":"BMC Pediatrics"},{"key":"10.1002\/14651858.CD010750.pub2-BIB0049|cit49","unstructured":"Association for Children\u2019s Palliative Care Children\u2019s palliative care definitions http:\/\/www.togetherforshortlives.org.uk\/assets\/0000\/1638\/CPC_definitions.pdf"},{"issue":"10","key":"10.1002\/14651858.CD010750.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1460-9592.2008.02764.x","article-title":"Paracetamol (acetaminophen): mechanisms of action","volume":"18","author":"Anderson","year":"2008","journal-title":"Pediatric Anesthesia"},{"key":"10.1002\/14651858.CD010750.pub2-BIB0051|cit51","unstructured":"Association for Paediatric Palliative medicine (APPM) Master Formulary 2015 Available at: http:\/\/www.appm.org.uk\/10.html"},{"key":"10.1002\/14651858.CD010750.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/med\/9780199595105.003.0017","article-title":"Chapter 17: Using medications in children","volume-title":"Oxford Textbook of Palliative Care for Children","author":"Ballantine","year":"2012"},{"issue":"1","key":"10.1002\/14651858.CD010750.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/pbc.22284","article-title":"End of life in children with cancer: experience at the Pediatric Oncology Department of the Istituto Nazionale Tumori in Milan","volume":"54","author":"Beretta","year":"2010","journal-title":"Pediatric Blood & Cancer"},{"key":"10.1002\/14651858.CD010750.pub2-BIB0054|cit54","volume-title":"British National Formulary for Children 2012-2013","author":"Paediatric Formulary Committee","year":"July 2012"},{"key":"10.1002\/14651858.CD010750.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/bja\/aeh042","article-title":"Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children","volume":"92","author":"Bouwmeester","year":"2004","journal-title":"British Journal of Anaesthesia"},{"issue":"1","key":"10.1002\/14651858.CD010750.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1089\/jpm.2005.8.86","article-title":"Cancer-related deaths in children and adolescents","volume":"8","author":"Bradshaw","year":"2005","journal-title":"Journal of Palliative Medicine"},{"key":"10.1002\/14651858.CD010750.pub2-BIB0057|cit57","doi-asserted-by":"crossref","unstructured":"Brook L Aindow A Jassel S Prescribing in paediatric palliative care: an association for paediatric palliative medicine survey BMJ Supportive & Palliative Care 2012 A24","DOI":"10.1136\/bmjspcare-2012-000196.70"},{"key":"10.1002\/14651858.CD010750.pub2-BIB0058|cit58","unstructured":"Cochrane H Liyanage S Nantambi R Palliative Care Statistics for Children and Young Adults Health and Care Partnerships Analysis. London: Department of Health, 2007"},{"key":"10.1002\/14651858.CD010750.pub2-BIB0059|cit59","unstructured":"Cochrane Pain Palliative and Supportive Care Review Group Authoring or Assessing a Cochrane Protocol, Review, or Review Update for the PaPaS Review Group [updated September 2011] http:\/\/papas.cochrane.org\/sites\/papas.cochrane.org\/files\/uploads\/L%20-%20PaPaSAuthor%26RefereeGuidance.pdf (accessed 19 July 2013)"},{"issue":"1","key":"10.1002\/14651858.CD010750.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0885-3924(03)00202-1","article-title":"The symptoms of dying children","volume":"26","author":"Drake","year":"2003","journal-title":"Journal of Pain and Symptom Management"},{"issue":"6","key":"10.1002\/14651858.CD010750.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1542\/peds.2010-3225","article-title":"Pediatric palliative care patients: a prospective multicenter cohort study","volume":"127","author":"Feudtner","year":"2011","journal-title":"Pediatrics."},{"issue":"4","key":"10.1002\/14651858.CD010750.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"e923","DOI":"10.1542\/peds.2011-2846","article-title":"Rising national prevalence of life-limiting conditions in children in England","volume":"129","author":"Fraser","year":"2012","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD010750.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"513-20","DOI":"10.1177\/0269216314528743","article-title":"Patterns of diagnoses among children and young adults with life-limiting conditions: A secondary analysis of a national dataset","volume":"28","author":"Fraser","year":"2014","journal-title":"Palliative Medicine"},{"issue":"6","key":"10.1002\/14651858.CD010750.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"e1179","DOI":"10.1542\/peds.2005-0683","article-title":"Symptoms in children\/young people with progressive malignant disease: United Kingdom Children's Cancer Study Group\/Paediatric Oncology Nurses Forum survey","volume":"117","author":"Goldman","year":"2006","journal-title":"Pediatrics"},{"issue":"10","key":"10.1002\/14651858.CD010750.pub2-BIB0065|cit65","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010270.pub2","article-title":"Transdermal fentanyl for cancer pain","author":"Hadley","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD010750.pub2-BIB0066|cit66","first-page":"288","article-title":"Children: different\uff0dbut the same species","volume":"18","author":"Hain","year":"2011","journal-title":"European Journal of Palliative Care"},{"issue":"1","key":"10.1002\/14651858.CD010750.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1472-684X-12-43","article-title":"Paediatric palliative care: development and pilot study of a 'Directory' of life-limiting conditions","volume":"12","author":"Hain","year":"2013","journal-title":"BMC Palliative Care"},{"issue":"3","key":"10.1002\/14651858.CD010750.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1055\/s-2008-1065347","article-title":"Parents' perspective on symptoms, quality of life, characteristics of death and end-of-life decisions for children dying from cancer","volume":"220","author":"Hechler","year":"2008","journal-title":"Klinische Padiatrie"},{"key":"10.1002\/14651858.CD010750.pub2-BIB0069|cit69","article-title":"Chapter 8. Assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. www.cochrane-handbook.org","author":"Higgins","year":"2011"},{"key":"10.1002\/14651858.CD010750.pub2-BIB0070|cit70","article-title":"Chapter 16. Special topics in statistics","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. www.cochrane-handbook.org","author":"Higgins","year":"2011"},{"issue":"1","key":"10.1002\/14651858.CD010750.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/jpm.2006.9.163","article-title":"Palliative care for infants, children, adolescents, and their families","volume":"9","author":"Himelstein","year":"2006","journal-title":"Journal of Palliative Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010750.pub2-BIB0072|cit72","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003469.pub4","article-title":"Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE)","author":"Hoare","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010750.pub2-BIB0073|cit73","unstructured":"International Association for the Study of Pain Taxonomy http:\/\/www.iasp-pain.org\/Content\/NavigationMenu\/GeneralResourceLinks\/PainDefinitions\/default.htm"},{"issue":"4","key":"10.1002\/14651858.CD010750.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.siny.2006.02.009","article-title":"Pain control: non-steroidal anti-inflammatory agents","volume":"11","author":"Jacqz-Aigrain","year":"2006","journal-title":"Seminars in Fetal and Neonatal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD010750.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1542\/peds.2005-1479","article-title":"Symptoms affecting children with malignancies during the last month of life: a nationwide follow-up","volume":"117","author":"Jalmsell","year":"2006","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD010750.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD010750.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/bdd.649","article-title":"Pharmacokinetic and pharmacodynamic study of morphine and morphine 6-glucuronide after oral and intravenous administration of morphine in children with cancer","volume":"30","author":"Mashayekhi","year":"2009","journal-title":"Biopharmaceutics & Drug Disposition"},{"issue":"6","key":"10.1002\/14651858.CD010750.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s40272-014-0092-2","article-title":"Pharmacological treatment of chronic non-cancer pain in pediatric patients","volume":"16","author":"Mathew","year":"2014","journal-title":"Paediatric Drugs"},{"key":"10.1002\/14651858.CD010750.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jpain.2008.04.007","article-title":"Core outcome domains and measures for pediatric acute and chronic\/recurrent pain clinical trials: PedIMMPACT recommendations","volume":"9","author":"McGrath","year":"2008","journal-title":"Journal of Pain"},{"issue":"4","key":"10.1002\/14651858.CD010750.pub2-BIB0080|cit80","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005088.pub2","article-title":"Bisphosphonate therapy for osteogenesis imperfecta","author":"Phillipi","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD010750.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s11136-010-9649-x","article-title":"Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study","volume":"19","author":"Ravens-Sieberer","year":"2010","journal-title":"Quality of Life Research"},{"issue":"6","key":"10.1002\/14651858.CD010750.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/ebm.13.6.162-a","article-title":"GRADE: assessing the quality of evidence for diagnostic recommendations","volume":"13","author":"Schunemann","year":"2008","journal-title":"Evidence-Based Medicine"},{"issue":"1-2","key":"10.1002\/14651858.CD010750.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pain.2006.05.006","article-title":"Systematic review of the psychometric properties, interpretability and feasibility of self-report pain intensity measures for use in clinical trials in children and adolescents","volume":"125","author":"Stinson","year":"2006","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD010750.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00005650-199902000-00003","article-title":"The PedsQL (TM): measurement model for the pediatric quality of life inventory","volume":"37","author":"Varni","year":"1999","journal-title":"Medical Care"},{"key":"10.1002\/14651858.CD010750.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pain.2009.03.002","article-title":"Three new datasets supporting use of the Numerical Rating Scale (NRS-11) for children's self-reports of pain intensity","volume":"143","author":"Baeyer","year":"2009","journal-title":"Pain"},{"key":"10.1002\/14651858.CD010750.pub2-BIB0086|cit86","unstructured":"World Health Organization Cancer Pain Relief, Second Edition, With a Guide to Opioid Availability Geneva: World Health Organisation, 1996"},{"key":"10.1002\/14651858.CD010750.pub2-BIB0087|cit87","unstructured":"World Health Organisation WHO Guidelines on Pharmacological Treatment of Persisting Pain in Children With Medical Illnesses Geneva: World Health Organisation, 2012"},{"issue":"5","key":"10.1002\/14651858.CD010750.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJM200002033420506","article-title":"Symptoms and suffering at the end of life in children with cancer","volume":"342","author":"Wolfe","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010750.pub2-BIB0089|cit89","first-page":"9","article-title":"Pain in children: comparison of assessment scales","volume":"14","author":"Wong D. Baker","year":"1988","journal-title":"Pediatric Nursing"},{"issue":"2","key":"10.1002\/14651858.CD010750.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2165\/00148581-200911020-00004","article-title":"Pediatric palliative care: use of opioids for the management of pain","volume":"11","author":"Zernikow","year":"2009","journal-title":"Pediatric Drugs"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD010750.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T15:51:49Z","timestamp":1691509909000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010750.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,13]]},"references-count":90,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010750.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,13]]}}}